Myriad’s 25-years of experience adds value to each step in the patient’s journey, ensuring precision in treatment and therapies and resulting in an overall cost savings to the healthcare system. This same commitment to accuracy, precision, and the best possible patient outcomes flows through all of Myriad’s products.

Outcomes

Medical management options proven to reduce disease-specific and overall mortality1,2,3

Physician Management

Proven medical management options are available for mutaion carriers

Report

Amended reports sent when new scientific discoveries are made
 

Interpretation

Published confidence in +/- predictive values: >99%3
Tools unique to Myriad: Pheno®, M-CO™

Identification

Patient tools/education
Physician protocol integration

Lab Analysis

Published analytical sensitivity: >99.98%4

Collection

Quality assurance: 93% of tests meet clinical criteria based on societal guidelines5


Learn More About Coverage

References:

  1. Domcheck S, et al. JAMA 2010; 304(9):967-75.
  2. Finch APM, et al. Journal of Clinical Oncology 2014; 32(15): 1547-1553.
  3. Metcalfe K, et al. BMJ 2014; 348:g226.
  4. Judkins T, et al. BMC Cancer 2015 Apr 2; 15:215.
  5. Myriad Genetic Laboratories, Inc. Clinical Quality Assurance Measures. April 2013.